ClassID:

20086

A61K9/1641 - page 3 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Recent Application in this class:
#601
20150150820
2015-06-04

Pharmaceutical compositions of pimobendan

#602
20150150789
2015-06-04

ANTIMICROBIAL COMPOSITIONS AND METHODS FOR PREVENTING INFECTION IN SURGICAL INCISION SITES

#603
20150148319
2015-05-28

Pharmaceutical formulation containing gelling agent

#604
20150133482
2015-05-14

Formulations of rifaximin and uses thereof

#605
20150079026
2015-03-19

Controlled release formulations for the induction and proliferation of blood cells

#606
20150072928
2015-03-12

Method for the production of emulsion-based microparticles

#607
20150071998
2015-03-12

Abuse resistant forms of immediate release oxymorphone, method of use and method of making

#608
20150071995
2015-03-12

Abuse resistant forms of extended release hydrocodone, method of use and method of making

#609
20150065549
2015-03-05

Bendamustine pharmaceutical compositions

#610
20150064246
2015-03-05

Abuse resistant forms of extended release oxymorphone, method of use and method of making

#611
20150064245
2015-03-05

Abuse resistant forms of immediate release hydromorphone, method of use and method of making

#612
20150057371
2015-02-26

Reversible, on-demand generation of aqueous two-phase microdroplets

#613
20150044270
2015-02-12

Sustained delivery of therapeutic agents to an eye compartment

#614
20150037413
2015-02-05

Tamper resistant dosage forms

#615
20150037412
2015-02-05

Tamper resistant dosage forms

#616
20150037411
2015-02-05

Tamper resistant dosage forms

#617
20150030686
2015-01-29

Self-assembled toroidal-spiral particles and manufacture and uses thereof

#618
20150028512
2015-01-29

Tamper resistant dosage forms

#619
20150025050
2015-01-22

Corticosteroids for the treatment of joint pain

#620
20150010616
2015-01-08

Biocompatible particles and method for preparing same

#621
20150005272
2015-01-01

Methods for treating edema in the eye and intraocular implants for use therefor

#622
20150004244
2015-01-01

Tamper-resistant pharmaceutical compositions of opioids and other drugs

#623
20150004102
2015-01-01

Nanoparticles comprising a vegetable hydrophobic protein and a water miscible non-volatile organic solvent and uses thereof

#624
20140377360
2014-12-25

Composition for controlled release of physiologically active substance

#625
20140377352
2014-12-25

Abuse resistant forms of extended release morphine, method of use and method of making

#626
20140377317
2014-12-25

17-hydroxyprogesterone ester containing oral compositions and related methods

#627
20140364497
2014-12-11

Pharmaceutical compositions of fenofibrate

#628
20140356437
2014-12-04

Corticosteroids for the treatment of joint pain

#629
20140342006
2014-11-20

Methods for Preparing Injectable Protein Microparticle Suspensions

#630
20140341984
2014-11-20

TAMPER RESISTANT PHARMACEUTICAL FORMULATIONS

#631
20140332438
2014-11-13

Water-soluble meloxicam granules

#632
20140322326
2014-10-30

Particles comprising a releasable dopant therein

#633
20140302000
2014-10-09

PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN

#634
20140287045
2014-09-25

Method of preparing microspheres by using polymer having sol-gel transition property and microspheres prepared thereby

#635
20140274929
2014-09-18

Stealth polymeric particles for delivery of bioactive or diagnostic agents

#636
20140271882
2014-09-18

17-hydroxyprogesterone ester containing oral compositions and related methods

#637
20140271875
2014-09-18

Compositions including encapsulated isotretinoin and methods for use thereof

#638
20140271489
2014-09-18

Polymeric depots for localization of agent to biological sites

#639
20140248344
2014-09-04

Abuse resistant forms of extended release morphine, method of use and method of making

#640
20140248343
2014-09-04

Abuse resistant forms of extended release morphine, method of use and method of making

#641
20140235530
2014-08-21

Spray drying vancomycin

#642
20140234418
2014-08-21

Method for treating intestinal fibrosis

#643
20140221447
2014-08-07

Formulation for preventing or reducing bleeding at a surgical site

#644
20140220147
2014-08-07

PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VII ENCAPSULATED IN MICELLES

#645
20140212493
2014-07-31

Highly Bioavailable Composition Containing Eprosartan - Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex

#646
20140206742
2014-07-24

Pharmaceutical composition with improved bioavailability

#647
20140205665
2014-07-24

Bioresorbable microparticles

#648
20140100161
2014-04-10

System and method for multiphasic release of growth factors

#649
20140093553
2014-04-03

Solid pharmaceutical and vaccine dose

#650
20140086991
2014-03-27

Controlled agglomeration

#651
20140073665
2014-03-13

Modified release compositions comprising tacrolimus

#652
20140066473
2014-03-06

Modified release compositions comprising tacrolimus

#653
20140065233
2014-03-06

Injectable microspheres for dermal augmentation and tissue bulking

#654
20140065225
2014-03-06

Modified release compositions comprising tacrolimus

#655
20140042654
2014-02-13

Fulvestrant nanosphere/microsphere and preparative method and use thereof

#656
20140031381
2014-01-30

Tamper resistant dosage forms

#657
20130344160
2013-12-26

Implantable bio-resorbable polymer charged with fragile macromolecules

#658
20130336884
2013-12-19

Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells

#659
20130330315
2013-12-12

Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug

#660
20130289235
2013-10-31

Kit for multifunctional compounds forming crosslinked biomaterials

#661
20130280272
2013-10-24

Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier

#662
20130274689
2013-10-17

Method for reducing transplant rejection in the eye and intraocular implants for use therefor

#663
20130273163
2013-10-17

Drug-delivery systems

#664
20130260015
2013-10-03

Tamper resistant dosage forms

#665
20130259940
2013-10-03

Tamper resistant dosage forms

#666
20130259939
2013-10-03

Tamper resistant dosage forms

#667
20130251802
2013-09-26

Tamper resistant dosage forms

#668
20130251799
2013-09-26

Tamper resistant dosage forms

#669
20130251798
2013-09-26

Tamper resistant dosage forms

#670
20130245055
2013-09-19

Pharmaceutical formulation containing gelling agent

#671
20130216609
2013-08-22

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#672
20130209390
2013-08-15

Process for producing drug-block copolymer composite and pharmaceutical preparation containing same

#673
20130197021
2013-08-01

Combination of active loaded granules with additional actives

#674
20130193028
2013-08-01

Water-soluble meloxicam granules

#675
20130189362
2013-07-25

Dosage formulation

#676
20130165448
2013-06-27

Aildenafil citrate crystal form O, preparation method and use thereof

#677
20130143877
2013-06-06

Composition comprising tetracyclic compound

#678
20130123373
2013-05-16

Use of polyether-based and vinyl monomer-based copolymers as binders for dosing forms comprising solid active ingredients

#679
20130122106
2013-05-16

DOSAGE FORM, AND METHODS OF MAKING AND USING THE SAME, TO PRODUCE IMMUNIZATION IN ANIMALS AND HUMANS

#680
20130122105
2013-05-16

Methods and compositions for gene therapy and GHRH therapy

#681
20130122103
2013-05-16

Electrostatically bonded vesicle

#682
20130052263
2013-02-28

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

#683
20130052142
2013-02-28

Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same

#684
20130046011
2013-02-21

HOT-MELT EXTRUDED COMPOSITIONS CONTAINING PLANT-DERIVED PHENOLIC MATERIALS AND PROCESSES FOR THE PREPARATION THEREOF

#685
20130045250
2013-02-21

Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative

#686
20130034608
2013-02-07

Long circulating nanoparticles for sustained release of therapeutic agents

#687
20130034550
2013-02-07

Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier

#688
20130029957
2013-01-31

17-hydroxyprogesterone ester-containing oral compositions and related methods

#689
20130023549
2013-01-24

Pharmaceutical compositions comprising nilotinib or its salt

#690
20130017228
2013-01-17

Methods and compositions for bone formation

#691
20130012683
2013-01-10

Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use

#692
20130009330
2013-01-10

Spray drying vancomycin

#693
20130004592
2013-01-03

Pharmaceutical compositions for parenteral administration

#694
20120328703
2012-12-27

Swellable particles for drug delivery

#695
20120328480
2012-12-27

MICROPARTICLE DISPERSION LIQUID MANUFACTURING METHOD AND MICROPARTICLE DISPERSION LIQUID MANUFACTURING APPARATUS

#696
20120321719
2012-12-20

Sustained delivery of therapeutic agents to an eye compartment

#697
20120315328
2012-12-13

Capsule of compound danshen dripping pills

#698
20120301518
2012-11-29

Biocompatible and biodegradable elastomeric polymers

#699
20120289594
2012-11-15

ORAL DOSAGE FORM

#700
20120288534
2012-11-15

Corticosteroids for the treatment of joint pain

#701
20120288487
2012-11-15

Biodegradable PAOX polymer particle with cationic property

#702
20120283332
2012-11-08

TRANSDERMAL DELIVERY OF METFORMIN

#703
20120282298
2012-11-08

CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN

#704
20120277323
2012-11-01

Cellulose capsules and methods for making them

#705
20120270949
2012-10-25

MELT-GRANULATED CINACALCET

#706
20120263760
2012-10-18

NOVEL FORMULATION OF METAXALONE

#707
20120258081
2012-10-11

Methods of treating proliferative diseases

#708
20120237605
2012-09-20

Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same

#709
20120214951
2012-08-23

PREPARATION OF POLYPHOSPHAZENE MICROSPHERES

#710
20120213708
2012-08-23

Hydrogel encapsulated cells and anti-inflammatory drugs

#711
20120202798
2012-08-09

Compositions controlling pH range of release and/or release rate

#712
20120201865
2012-08-09

HOT-MELT EXTRUDED COMPOSITIONS CONTAINING PLANT-DERIVED PHENOLIC MATERIALS AND PROCESSES FOR THE PREPARATION THEREOF

#713
20120196873
2012-08-02

STABILIZATION OF AMORPHOUS DRUGS USING SPONGE-LIKE CARRIER MATRICES

#714
20120195980
2012-08-02

Method, composition and package for bowel cleansing

#715
20120190667
2012-07-26

Method of making solid dispersions of highly crystalline therapeutic compounds

#716
20120183623
2012-07-19

Pellets coated with coatings containing active substances

#717
20120183606
2012-07-19

Drug delivery system comprising polyoxazoline and a bioactive agent

#718
20120164209
2012-06-28

Abuse resistant oral opioid formulations

#719
20120156277
2012-06-21

Abuse resistant forms of immediate release oxycodone, method of use and method of making

#720
20120156128
2012-06-21

CONTROLLABLE RELEASE COMPOSITION AND METHOD FOR PREPARING SAME

#721
20120149727
2012-06-14

Prasugrel in non-crystalline form and pharmaceutical composition thereof

#722
20120146255
2012-06-14

Process For Producing Pellets Comprising At Least One Water-Soluble Component

#723
20120135058
2012-05-31

NANODISPERSIONS

#724
20120134940
2012-05-31

NANODISPERSIONS

#725
20120129798
2012-05-24

Stealth polymeric particles for delivery of bioactive or diagnostic agents

#726
20120128783
2012-05-24

Compositions and methods for delivery of frozen particle adhesives

#727
20120122914
2012-05-17

Sustained-release composition containing tetrahydropyrido[4,3-b]indole derivatives and preparation of the derivatives

#728
20120121718
2012-05-17

COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION

#729
20120114756
2012-05-10

Sustained-release drug carrier composition

#730
20120114751
2012-05-10

PHARMACEUTICAL COMPOSITION FOR TREATING HCV INFECTIONS

#731
20120109613
2012-05-03

Compositions and methods for biological remodeling with frozen particle compositions

#732
20120108622
2012-05-03

Pharmaceutical formulation containing gelling agent

#733
20120107399
2012-05-03

Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient

#734
20120107367
2012-05-03

Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules

#735
20120107241
2012-05-03

Particles for Inhalation Having Sustained Release Properties

#736
20120101738
2012-04-26

Compositions and methods for biological remodeling with frozen particle compositions

#737
20120087978
2012-04-12

DOSAGE FORMS OF APIXABAN

#738
20120082733
2012-04-05

Methods for processing microspheres

#739
20120082729
2012-04-05

QUICK DISSOLVE COMPOSITIONS AND TABLETS BASED THEREON

#740
20120077835
2012-03-29

FORMULATIONS OF RIFAXIMIN AND USES THEREOF

#741
20120065329
2012-03-15

Synthesis of stable elastomeric negative acoustic contrast particles

#742
20120064639
2012-03-15

Stable elastomeric negative acoustic contrast particles and their use in acoustic radiation fields

#743
20120059462
2012-03-08

METHODS FOR REDUCING OR PREVENTING TRANSPLANT REJECTION IN THE EYE AND INTRAOCULAR IMPLANTS FOR USE THEREFOR

#744
20120053303
2012-03-01

Branched Polyesters Based On Citric Acid, Their Preparation And Use

#745
20120053238
2012-03-01

SOLID RETIGABINE IN NON-CRYSTALLINE FORM

#746
20120045396
2012-02-23

POROUS STRUCTURES WITH MODIFIED BIODEGRADATION KINETICS

#747
20120040899
2012-02-16

Method for treating hyperglycemia

#748
20120040397
2012-02-16

Photo-Crosslinked Nucleic Acid Hydrogels

#749
20120029009
2012-02-02

Tacrolimus for improved treatment of transplant patients

#750
20120027855
2012-02-02

PHARMACEUTICAL COMPOSITIONS FOR GASTROINTESTINAL DRUG DELIVERY

#751
20120027822
2012-02-02

Process for Producing Rapidly Disintegrating Spheroids (Pellets), Granules and/or Mixtures Thereof

#752
20120022087
2012-01-26

AMORPHOUS AMBRISENTAN

#753
20120022079
2012-01-26

Method for producing preparations of substances poorly soluble in water

#754
20120022034
2012-01-26

METHODS FOR REDUCING OR NEOVASCULARIZATION OR EDEMA

#755
20120021018
2012-01-26

MICROSPHERES FOR THE SUSTAINED RELEASE OF OCTREOTIDE WITH A LOW INITIAL BURST

#756
20120009258
2012-01-12

COMPACTED CINACALCET

#757
20120003230
2012-01-05

Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier

#758
20110318420
2011-12-29

Fulvestrant nanosphere/microsphere and preparative method and use thereof

#759
20110318418
2011-12-29

Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine

#760
20110313050
2011-12-22

SOLID COMPOSITION CONTAINING THE INGREDIENT RASAGILINE

#761
20110306632
2011-12-15

Solid dispersions containing kinase inhibitors

#762
20110305754
2011-12-15

Controlled release micro-capsule for osteogenic action

#763
20110293690
2011-12-01

Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof

#764
20110285043
2011-11-24

Microparticle dispersion liquid manufacturing method and microparticle dispersion liquid manufacturing apparatus

#765
20110275659
2011-11-10

Tacrolimus For Improved Treatment Of Transplant Patients

#766
20110274758
2011-11-10

Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes

#767
20110268803
2011-11-03

Lung targeting dual drug delivery system

#768
20110263632
2011-10-27

Solid dispersions comprising tacrolimus

#769
20110256190
2011-10-20

Modified release compositions comprising tacrolimus

#770
20110251232
2011-10-13

Modified release compositions comprising tacrolimus

#771
20110251231
2011-10-13

Modified release compositions comprising tacrolimus

#772
20110250277
2011-10-13

Modified release compositions comprising tacrolimus

#773
20110243988
2011-10-06

Methods and Compositions for Stabilization of a Virus Vaccine

#774
20110237623
2011-09-29

Sustained-release donepezil formulation

#775
20110217382
2011-09-08

Methods and compositions for treating pain comprising a statin

#776
20110217377
2011-09-08

Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents

#777
20110212985
2011-09-01

Naltrexone Long Acting Formulations and Methods of Use

#778
20110189272
2011-08-04

Pharmaceutical preparation containing gabapentin

#779
20110184007
2011-07-28

Pharmaceutical compositions configured to deter dosage form splitting

#780
20110178183
2011-07-21

Use Of Polyether-Based And Vinyl Monomer-Based Copolymers As Binders For Dosing Forms Comprising Solid Active Ingredients

#781
20110177231
2011-07-21

Nano-, Micro-, Macro- Encapsulation And Release Of Materials

#782
20110171140
2011-07-14

Absorption of therapeutic agents across mucosal membranes or the skin

#783
20110165248
2011-07-07

PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(E-CAPROLACTONE)

#784
20110165064
2011-07-07

Methods and compositions related to clot-binding compounds

#785
20110159090
2011-06-30

Abuse resistant drugs, method of use and method of making

#786
20110159089
2011-06-30

Abuse resistant forms of extended release morphine, method of use and method of making

#787
20110150991
2011-06-23

Abuse resistant forms of extended release morphine with oxycodone, method of use and method of making

#788
20110150990
2011-06-23

Abuse resistant forms of extended release hydrocodone, method of use and method of making

#789
20110150971
2011-06-23

Abuse resistant forms of extended release oxymorphone, method of use and method of making

#790
20110150970
2011-06-23

Abuse resistant forms of extended release oxycodone, method of use, and method of making

#791
20110150969
2011-06-23

Abuse resistant forms of extended release hydromorphone, method of use and method of making

#792
20110150837
2011-06-23

Amphiphilic polymer functionalized by methionine

#793
20110150765
2011-06-23

Frozen compositions and methods for piercing a substrate

#794
20110144181
2011-06-16

Pharmaceutical Compositions of Amorphous Atorvasta and Process for Preparing Same

#795
20110142952
2011-06-16

Pharmaceutical Compositions

#796
20110142943
2011-06-16

Tamper-resistant pharmaceutical compositions of opioids and other drugs

#797
20110136883
2011-06-09

GRANULATION OF ACTIVE PHARMACEUTICAL INGREDIENTS

#798
20110135738
2011-06-09

SINGLE DOSAGE PHARMACEUTICAL FORMULATION COMPRISING EPROSARTAN MESYLATE

#799
20110130616
2011-06-02

Magnetically responsive nanoparticle therapeutic constructs and methods of making and using

#800
20110129941
2011-06-02

Method of producing polymeric particles with selected size, shape, morphology and composition

#801
20110129538
2011-06-02

PROCESS FOR PREPARING ORALLY ADMINISTERED DABIGATRAN FORMULATIONS

#802
20110123631
2011-05-26

Oral compositions of clindamycin

#803
20110118825
2011-05-19

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#804
20110117024
2011-05-19

Nanocarrier and nanogel compositions

#805
20110112160
2011-05-12

TABLET COMPRISING EPROSARTAN MESYLATE

#806
20110097375
2011-04-28

FORMULATION FOR PREVENTING OR REDUCING BLEEDING AT A SURGICAL SITE

#807
20110086104
2011-04-14

Residual solvent extraction method and microparticles produced thereby

#808
20110086019
2011-04-14

POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTSMETHODS FOR

#809
20110082214
2011-04-07

Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet

#810
20110076325
2011-03-31

Abuse resistant drugs, method of use and method of making

#811
20110071612
2011-03-24

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#812
20110070303
2011-03-24

NOVEL DOSAGE FORMULATION

#813
20110066251
2011-03-17

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#814
20110064820
2011-03-17

Pharmaceutical compositions comprising phosphate-binding polymer

#815
20110052710
2011-03-03

Nanoparticles for delivery of active agents

#816
20110052709
2011-03-03

Nanoparticles for delivery of active agents

#817
20110034489
2011-02-10

SOLID DOSAGE FORMS OF HIV PROTEASE INHIBITORS

#818
20110033543
2011-02-10

Hydrogels with covalent and noncovalent crosslinks

#819
20110033508
2011-02-10

Injectable microspheres for dermal augmentation and tissue bulking

#820
20110027377
2011-02-03

Immediate release pharmaceutical granule compositions and a continuous process for making them

#821
20110018154
2011-01-27

Preparation method for solid dispersions

#822
20110009570
2011-01-13

Preparation of polyphosphazene microspheres

#823
20110008454
2011-01-13

Immediate release pharmaceutical granule compositions and a continuous process for making them

#824
20110002985
2011-01-06

Abuse resistant oral opioid formulations

#825
20100330147
2010-12-30

Drug delivery compositions including nanoshells for triggered drug release

#826
20100329984
2010-12-30

Respiratory dispersion for metered dose inhalers comprising perforated microstructures

#827
20100317110
2010-12-16

Cell-mediated delivery and targeted erosion of noncovalently crosslinked hydrogels

#828
20100316717
2010-12-16

Injectable hydrogel microspheres from aqueous two-phase system

#829
20100311808
2010-12-09

Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules

#830
20100310669
2010-12-09

Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof

#831
20100310660
2010-12-09

DRY POWDER MICROPARTICLES FOR PULMONARY DELIVERY

#832
20100303908
2010-12-02

PHARMACEUTICAL COMPOSITION COMPRISING DESLORATADINE

#833
20100303900
2010-12-02

PREPARATION OF INJECTABLE SUSPENSIONS HAVING IMPROVED INJECTABILITY

#834
20100297238
2010-11-25

Multifunctional and biologically active matrices from multicomponent polymeric solutions

#835
20100292314
2010-11-18

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#836
20100291116
2010-11-18

MICROPARTICLE COMPRISING CROSS-LINKED POLYMER

#837
20100285114
2010-11-11

PHARMACEUTICAL COMPOSITIONS OF RHEIN OR DIACEREIN

#838
20100278909
2010-11-04

PROCESS FOR FORMING SOLID ORAL DOSAGE FORMS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS

#839
20100272823
2010-10-28

Pulmonary delivery particles comprising an active agent

#840
20100263675
2010-10-21

Condom with Localized Active Agent

#841
20100260855
2010-10-14

Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes

#842
20100260850
2010-10-14

Controlled Release Devices and Methods for Delivery of Nucleic Acids

#843
20100260846
2010-10-14

Particles for delivery of nucleic acids and related devices and methods

#844
20100260763
2010-10-14

Polypeptides, antibody variable domains and antagonists methods for

#845
20100255095
2010-10-07

Pharmaceutical compositions of fenofibrate

#846
20100254995
2010-10-07

POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS AND ANTAGONISTS

#847
20100254972
2010-10-07

METHODS FOR SELECTING PROTEASE RESISTANT POLYPEPTIDES

#848
20100240742
2010-09-23

Anti-angiogenic nanoparticle compositions

#849
20100233083
2010-09-16

MICROPARTICLES COMPRISING A CROSSLINKED POLYMER

#850
20100216804
2010-08-26

Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents

#851
20100215719
2010-08-26

Polyarylates for drug delivery and tissue engineering

#852
20100209525
2010-08-19

Methods for preparing polymer microparticles

#853
20100203153
2010-08-12

SUSTAINED-RELEASE NANOPARTICLE COMPOSITIONS AND METHODS USING THE SAME

#854
20100203131
2010-08-12

Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine

#855
20100203090
2010-08-12

Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine

#856
20100187728
2010-07-29

Systems, devices, and methods for making or administering frozen particles

#857
20100185174
2010-07-22

Systems, devices, and methods for making or administering frozen particles

#858
20100183687
2010-07-22

PROCESS FOR PREPARING PARTICLES OF OPIOIDS AND COMPOSITIONS PRODUCED THEREBY

#859
20100178353
2010-07-15

QUICK DISSOLVE COMPOSITIONS AND TABLETS BASED THEREON

#860
20100172998
2010-07-08

PROCESS FOR PREPARING MICROPARTICLES THROUGH PHASE INVERSION PHENOMENA

#861
20100172969
2010-07-08

HOT-MELT MICROPELLETS

#862
20100168900
2010-07-01

Systems, devices, and methods for making or administering frozen particles

#863
20100168148
2010-07-01

Pharmaceutical formulation containing gelling agent

#864
20100163576
2010-07-01

Systems, devices, and methods for making or administering frozen particles

#865
20100152880
2010-06-17

Systems, devices and methods for making or administering frozen particles

#866
20100152651
2010-06-17

Frozen compositions and methods for piercing a substrate

#867
20100143243
2010-06-10

Frozen compositions and methods for piercing a substrate

#868
20100137213
2010-06-03

Formulations of single domain antigen binding molecules

#869
20100121466
2010-05-13

Frozen compositions and methods for piercing a substrate

#870
20100120723
2010-05-13

PHARMACEUTICAL COMPOSITION COMPRISING A HOT-MELT GRANULATED LUBRICANT

#871
20100119570
2010-05-13

Solid Pharmaceutical And Vaccine Dose

#872
20100119557
2010-05-13

Frozen compositions and array devices thereof

#873
20100114547
2010-05-06

Compositions and methods for biological remodeling with frozen particle compositions

#874
20100114348
2010-05-06

Frozen compositions and methods for piercing a substrate

#875
20100113615
2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#876
20100113614
2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#877
20100112093
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#878
20100112068
2010-05-06

Compositions and methods for biological remodeling with frozen particle compositions

#879
20100112067
2010-05-06

Compositions and methods for biological remodeling with frozen particle compositions

#880
20100112057
2010-05-06

Multifunctional and biologically active matrices from multicomponent polymeric solutions

#881
20100111857
2010-05-06

Compositions and methods for surface abrasion with frozen particles

#882
20100111855
2010-05-06

Frozen piercing implements and methods for piercing a substrate

#883
20100111854
2010-05-06

Frozen compositions and methods for piercing a substrate

#884
20100111848
2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#885
20100111847
2010-05-06

Compositions and methods for administering compartmentalized frozen particles

#886
20100111846
2010-05-06

Compositions and methods for delivery of frozen particle adhesives

#887
20100111845
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#888
20100111844
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#889
20100111843
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#890
20100111842
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#891
20100111841
2010-05-06

Compositions and methods for surface abrasion with frozen particles

#892
20100111837
2010-05-06

Compositions and methods for biological remodeling with frozen particle compositions

#893
20100111836
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#894
20100111835
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#895
20100111834
2010-05-06

Compositions and methods for therapeutic delivery with frozen particles

#896
20100111833
2010-05-06

Compositions and methods for surface abrasion with frozen particles

#897
20100105717
2010-04-29

Tacrolimus for improved treatment of transplant patients

#898
20100087501
2010-04-08

Highly Bioavailable Composition Containing Eprosartan-Poloxamer Complex or 2-(7-Chloro-5-Methyl-4-Oxo-3-Phenyl-4,5-Dihydro-3H-Pyridazine (4,5-b)Indol-1-yl)-N,N-Dimethylacetamide - Poloxamer Complex

#899
20100087463
2010-04-08

Pharmaceutical compositions comprising nilotinib hydrochloride monohydrate

#900
20100086597
2010-04-08

MICROSPHERES FOR THE SUSTAINED RELEASE OF OCTREOTIDE WITH A LOW INITIAL BURST